DRMA
Dermata Therapeutics, Inc.
$1.34
+0.00 (+0.00%)
At close · Jul 6
Market Cap
$5.39M
Shares
4,022,143
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-27 | — | |
| 8-K | 2026-05-13 | 2026-03-31 | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| DEF 14A | 2026-04-17 | — | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-03-26 | — | |
| 8-K | 2026-02-25 | 2026-02-23 | |
| 8-K | 2026-02-03 | 2026-01-30 | |
| 8-K | 2026-01-27 | — | |
| 8-K | 2025-12-29 | 2025-12-23 | |
| 8-K | 2025-11-18 | 2025-11-17 | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-11-14 | — | |
| 8-K | 2025-11-07 | — | |
| 8-K | 2025-09-17 | — | |
| 8-K | 2025-09-10 | — | |
| 8-K | 2025-08-25 | 2025-08-22 | |
| 8-K | 2025-08-13 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-07-30 | — | |
| 8-K | 2025-07-16 | 2025-07-15 | |
| 8-K | 2025-07-07 | 2025-07-02 | |
| 8-K | 2025-06-05 | 2025-06-03 | |
| DEF 14A | 2025-06-02 | — | |
| 8-K | 2025-05-21 | 2025-05-20 | |
| 8-K | 2025-05-16 | 2025-05-14 | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-04-15 | — | |
| 8-K | 2025-03-28 | 2025-03-27 | |
| 8-K | 2025-03-27 | — | |
| 8-K | 2025-03-25 | — | |
| 10-K | 2025-03-17 | 2024-12-31 | |
| 8-K | 2025-03-17 | — | |
| 8-K | 2025-01-23 | 2025-01-21 | |
| 8-K | 2025-01-21 | 2025-01-17 | |
| 8-K | 2024-11-14 | 2024-11-13 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-09-17 | 2024-09-16 | |
| 8-K | 2024-08-07 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-02 | — | |
| 8-K | 2024-06-07 | — | |
| 8-K | 2024-06-05 | 2024-06-04 | |
| 8-K | 2024-05-24 | 2024-05-20 | |
| 8-K | 2024-05-17 | — | |
| 8-K | 2024-05-15 | — | |
| 8-K | 2024-05-15 | 2024-05-14 | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-05-14 | — |
Showing 1–50 of 102 filings